|  | Prevalence of HR (%) |  |  |  |  | ||
---|---|---|---|---|---|---|---|---|
Serum Uric Acid (mg/dl) | N | Total | Males | Females | Model 1 | Model 2 | ||
 |  |  |  |  | OR, 95% CI | P | OR, 95% CI | P |
Continuous variable | 12,966 | 75.95 | 77.90 | 74.60 | 1.10 (1.07, 1.13) | <0.001 | 1.06 (1.02, 1.10) | 0.002 |
Quartiles | ||||||||
 Q1 (<4.4) | 3201 | 73.38 | 76.73 | 72.75 | 1 |  | 1 |  |
 Q2 (4.4–5.3) | 3248 | 74.26 | 75.95 | 73.51 | 1.05 (0.936, 1.17) | 0.423 | 1.00 (0.891, 1.13) | 0.982 |
 Q3 (5.3–6.4) | 3259 | 76.65 | 77.22 | 76.15 | 1.19 (1.06, 1.33) | 0.002 | 1.12 (0.988, 1.27) | 0.076 |
 Q4 (≥6.5) | 3258 | 79.47 | 79.62 | 79.16 | 1.40 (1.25, 1.58) | <0.001 | 1.21 (1.05, 1.40) | 0.008 |
Binary Classification | ||||||||
 Non-hyperuricemia | 10,007 | 74.97 | 77.00 | 73.60 | 1 |  | 1 |  |
 Hyperuricemia | 2959 | 79.48 | 80.40 | 78.50 | 1.28 (1.16, 1.42) | <0.001 | 1.18 (1.05, 1.33) | 0.004 |